Citigroup Raises Ionis Pharmaceuticals (NASDAQ:IONS) Price Target to $84.00
Citigroup upped their price target on Ionis Pharmaceuticals from $69.00 to $84.00 and gave the company a “buy” rating in a research report on Wednesday.
Source link
Similar Posts
HAL – Halo Technologies Holdings Ltd
Halo Technologies Holdings Limited (HAL) is an online global equities research and trade execution software solution that brings institutional-grade analytical frameworks and market insights to investors. HALO’s investment software solution offering can be divided into two integrated elements – HALO Global and HALO Trading. Listing date 26 April 2022 1:30PM AEST ## Company contact details…
WTI Crude Oil: The Tug-of-War Between Geopolitical Risk and Oversupply Fears
WTI Crude Oil: The Tug-of-War Between Geopolitical Risk and Oversupply Fears Hello, fellow traders! The WTI crude oil market is currently caught in a volatile tug-of-war. Trading around the $59 per barrel mark as of December 3rd, prices are oscillating as the market attempts to balance immediate supply constraints against looming expectations of significant future…
The Aussie Dollar’s Secret: Why Your Currency Is a Mining Stock in Disguise – Fat Tail Daily
Today, I thought we’d dive into the Aussie Dollar as a potential long-term bellwether for understanding our position in the resource market. So, how do commodities have a bearing on a nation’s currency? Simply put, the Australian economy derives a significant portion of its income from commodity exports, which fuel what’s known as its Terms…
How I Made $49 in One Day Using an Old Indicator
Today I decided to trade using the signals of my old indicator. I traded on audusd m5 timeframe. Great result, today I earned $49. Buy signal: up arrow. If there are open sell positions, they need to be closed. Sell signal: downward arrow. If there are open buy positions, they need to be closed. There are situations when several signals appear…
Ola Electric shares in focus as CCPA seeks more documents amid probe
Ola Electric Mobility shares will remain in focus on Monday, January 13, after the Central Consumer Protection Authority (CCPA) has sought additional documents from the company as part of its ongoing investigation into the electric two-wheeler manufacturer. “In continuation of the earlier letter received from the Central Consumer Protection Authority dated December 04, 2024, by…
